Torsten Tonn Highlights Breakthrough in Blood Pharming: miRNA-30a-5p Knockout Restores Red Cell Differentiation
Torsten Tonn, Professor for Transfusion Medicine and Molecular Hematology, shared an insightful post on LinkedIn:
“Congratulation to Romy Kronstein Wiedemann and Jessica Thiel and colleagues in our Dresden Institute for Transfusion Medicine. This paper reports previously unkown mechanisms that account for the ineffective in vitro differentiation of red blood cells from immortalized stem cell sources. This is an important step towards to making blood pharming a reality!”
Read the full article here:
Article: Knock Out of miRNA-30a-5p and Reconstitution of the Actin Network Dynamics Partly Restores the Impaired Terminal Erythroid Differentiation during Blood Pharming
Authors: Jessica Thiel, Duran Sürün, Desiree C. Brändle, Madeleine Teichert, Stephan R. Künzel, Ulrike Friedrich, Andreas Dahl, Kristin Schubert, Ignacy Rzagalinski, Andrej Shevchenko, Sofia Traikov, Peter Mirtschink, Lisa Wagenführ, Frank Buchholz, Kristina Hölig, Torsten Tonn, Romy Kronstein-Wiedemann
Stay updated with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome